Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: Gilead Sciences vs. Amgen


Times are certainly changing for Gilead Sciences (NASDAQ: GILD) and Amgen (NASDAQ: AMGN).

Both of these big biotechs are shifting their therapeutic focuses. Both hope to change their future prospects for the better in the process. Which of these biotech stocks is more likely to be the bigger winner for investors? Here's how Gilead and Amgen stack up against each other.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments